153 related articles for article (PubMed ID: 37080190)
1. Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis.
Ke Wang M; Heo R; Meyre PB; Blum S; Park L; Birchenough L; Vuong K; McIntyre WF; Healey JS; Devereaux PJ; McMullen M; Mrkobrada M; Pinilla-Echeverri N; Styles K; Conen D
Swiss Med Wkly; 2023 Apr; 153():40056. PubMed ID: 37080190
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials.
Benz AP; Johansson I; Dewilde WJM; Lopes RD; Mehran R; Sartori S; Sarafoff N; Yasuda S; McIntyre WF; Healey JS; Shoamanesh A; Eikelboom JW; Connolly SJ
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):648-659. PubMed ID: 34142118
[TBL] [Abstract][Full Text] [Related]
4. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
[TBL] [Abstract][Full Text] [Related]
5. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
[TBL] [Abstract][Full Text] [Related]
6. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ntaios G; Papavasileiou V; Makaritsis K; Vemmos K; Michel P; Lip GYH
Stroke; 2017 Sep; 48(9):2494-2503. PubMed ID: 28716982
[TBL] [Abstract][Full Text] [Related]
7. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
[TBL] [Abstract][Full Text] [Related]
8. Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis.
Reddin C; Judge C; Loughlin E; Murphy R; Costello M; Alvarez A; Ferguson J; Smyth A; Canavan M; O'Donnell MJ
Stroke; 2021 Oct; 52(10):3151-3162. PubMed ID: 34281383
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Undergoing Elective Surgical Procedures: A Meta-analysis.
Siddiqui MU; Pasha AK; Rauf I; Lee JZ; Siddiqui MD; Yaacoub Y; Movahed MR
Clin Med Res; 2021 Mar; 19(1):19-25. PubMed ID: 33060109
[No Abstract] [Full Text] [Related]
11. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT; Giugliano RP; Braunwald E; Hoffman EB; Deenadayalu N; Ezekowitz MD; Camm AJ; Weitz JI; Lewis BS; Parkhomenko A; Yamashita T; Antman EM
Lancet; 2014 Mar; 383(9921):955-62. PubMed ID: 24315724
[TBL] [Abstract][Full Text] [Related]
12. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Deng Y; Tong Y; Deng Y; Zou L; Li S; Chen H
J Am Heart Assoc; 2019 Jul; 8(14):e012540. PubMed ID: 31310583
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.
Dogliotti A; Paolasso E; Giugliano RP
Clin Cardiol; 2013 Feb; 36(2):61-7. PubMed ID: 23338902
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
16. Safety of Direct Oral Anticoagulants Compared to Warfarin for Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis.
Hage A; Dolan DP; Nasr VG; Castelo-Branco L; Motta-Calderon D; Ghandour H; Hage F; Papatheodorou S; Chu MWA
Semin Thorac Cardiovasc Surg; 2022; 34(3):947-957. PubMed ID: 34111554
[TBL] [Abstract][Full Text] [Related]
17. Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis.
He W; Zhang H; Zhu W; Xue Z
Medicine (Baltimore); 2019 Oct; 98(42):e17628. PubMed ID: 31626146
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
Dentali F; Riva N; Crowther M; Turpie AG; Lip GY; Ageno W
Circulation; 2012 Nov; 126(20):2381-91. PubMed ID: 23071159
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
20. Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
Lip GYH; Merino JL; Dan GA; Themistoclakis S; Ellenbogen KA; De Caterina R; Goudev A; Jin J; Melino M; Winters SM; Goette A
Am J Cardiol; 2018 Jan; 121(2):193-198. PubMed ID: 29169605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
